EPISODE · Dec 22, 2021 · 9 MIN
Potential Relapsing MS Therapy Up for FDA Approval & Trying a New Diet with MS
from MS News & Perspectives · host MS News Today
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how TG Therapeutics is seeking FDA approval for ublituximab, its anti-CD20 monoclonal antibody infusion therapy for RRMS and SPMS with relapses; and reads the column by Jamie Hughes, A Life in Letters, “Listening to My Body as I Experiment With a New Diet”.=================================== Are you interested in learning more about multiple sclerosis? If so, please visit: https://multiplesclerosisnewstoday.com/ =====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/
NOW PLAYING
Potential Relapsing MS Therapy Up for FDA Approval & Trying a New Diet with MS
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m